GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma Trading AD (XBUL:SFT) » Definitions » EPS (Basic)

Sopharma Trading AD (XBUL:SFT) EPS (Basic) : лв1.25 (TTM As of Dec. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Sopharma Trading AD EPS (Basic)?

Sopharma Trading AD's basic earnings per share (Basic EPS) for the three months ended in Dec. 2024 was лв0.32. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was лв1.25.

Sopharma Trading AD's EPS (Diluted) for the three months ended in Dec. 2024 was лв0.31. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was лв1.24.

Sopharma Trading AD's EPS without NRI for the three months ended in Dec. 2024 was лв0.35. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was 1.24.

During the past 12 months, Sopharma Trading AD's average EPS without NRIGrowth Rate was 45.90% per year. During the past 3 years, the average EPS without NRI Growth Rate was 54.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 39.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 12.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Sopharma Trading AD's highest 3-Year average EPS without NRI Growth Rate was 54.10% per year. The lowest was -9.70% per year. And the median was 10.80% per year.


Sopharma Trading AD EPS (Basic) Historical Data

The historical data trend for Sopharma Trading AD's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma Trading AD EPS (Basic) Chart

Sopharma Trading AD Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 0.23 0.26 0.85 1.25

Sopharma Trading AD Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.39 0.31 0.23 0.32

Sopharma Trading AD EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Sopharma Trading AD's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(42.76-0)/34.208
=1.25

Sopharma Trading AD's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(10.756-0)/34.007
=0.32

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was лв1.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sopharma Trading AD  (XBUL:SFT) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Sopharma Trading AD EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Sopharma Trading AD's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Sopharma Trading AD Business Description

Traded in Other Exchanges
N/A
Address
Sunrise Street, Lachezar Stanchev, 5 Sopharma, Business Towers, Building A Floor 12, Sofia, BGR, 1756
Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.

Sopharma Trading AD Headlines

No Headlines